Status:

UNKNOWN

Efficacy of the "Milk Ladder" Intervention in the Development of Tolerance and the Recognition of B Cell Epitopes in Babies Who Are Allergic to Cow's Milk Proteins

Lead Sponsor:

Hospital San Carlos, Madrid

Conditions:

IgE-mediated Milk Allergy

Eligibility:

All Genders

1-12 years

Phase:

NA

Brief Summary

Food allergies have become a relevant health problem in westernized societies, particularly, with children. Cow's milk (CM), along with hen's eggs, are the most common foods eliciting allergic reactio...

Eligibility Criteria

Inclusion

  • Babies of both sexes.
  • Age \< 12 months.
  • Clinical history of immediate reaction (\<2 hours) after the intake of baby's formula and/or foods containing cow's milk.
  • Sensitization to cow's milk proteins demonstrated by:
  • sIgE to cow's milk, alpha-Lactoabumin, beta-Lactoglobulin and/or Casein \>0.1KU/l (ImmunoCAP®, ThemoFisher) and/or
  • Skin prick test to cow's milk, alpha-Lactoabumin, beta-Lactoglobulin and/or Casein ≥3mm
  • If the reaction to milk occurred over 3 months before the recruitment, it will be mandatory to confirm reactivity to milk with an oral food test.
  • Parents / legal representatives of the participant voluntary accept to participate.

Exclusion

  • Delayed reactions (\> 2 h) after milk intake.
  • Contact urticaria to milk if ingestion is well tolerated.
  • Previous participation in oral tolerance induction/desensitization protocols.
  • Treatment with any medication that might interfere the evaluation of the primary outcome or any study procedure.
  • Any disease or condition which presents a contraindication to perform an oral challenge, either open or double-blind or any other study procedure.
  • Social circumstances that might interfere with protocol adherence.
  • Egg and/or wheat allergy (this exclusion criterion shall be verified before the beginning of the intervention).

Key Trial Info

Start Date :

June 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 30 2021

Estimated Enrollment :

114 Patients enrolled

Trial Details

Trial ID

NCT03466931

Start Date

June 1 2018

End Date

August 30 2021

Last Update

June 26 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Clinico San Carlos

Madrid, Spain, 28040